BioNTech SE Research And Development Expense

• BioNTech SE showed a decrease of -6.6% in Research And Development Expense from 2024 to 2025.
• This data is from BioNTech SE's annual report (Form 10-K), filed with the SEC on March 10, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), BioNTech SE's Research And Development Expense has grown by 2,362.0%.
• Historical annual values: Fiscal year 2025: $2.10 billion | Fiscal year 2024: $2.25 billion | Fiscal year 2023: $1.78 billion | Fiscal year 2022: $1.54 billion | Fiscal year 2021: $949.20 million | Fiscal year 2020: $645.00 million | Fiscal year 2019: $226.50 million | Fiscal year 2018: $143.04 million | Fiscal year 2017: $85.50 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026